US Patent RE47885 Use of cannabidiol prodrugs in pharmaceutical compositions
Patent RE47885 was granted and assigned to Zynerba Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent RE47885 Use of cannabidiol prodrugs in pharmaceutical compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
